There are currently 202 clinical trials in Oakland, California looking for participants to engage in research studies. Trials are conducted at various facilities, including Kaiser Permanente-Oakland, CCOP - Bay Area Tumor Institute, UCSF Benioff Children's Hospital Oakland and Alta Bates Summit Medical Center - Summit Campus. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Teletherapy in Children Who Are Deaf and Hard of Hearing
NCT04928209
Recruiting
This study seeks to determine the effectiveness of speech/language teletherapy to address disparities in speech and language outcomes in children who are deaf or hard-of-hearing (D/HH). The investigators will enroll D/HH children aged 0-27 months. 140 children who are publicly insured will be randomized to receive usual clinical care or to be given access to an 18-month course of speech-language teletherapy program. 70 children who are privately insured will also be enrolled and will receive usu... Read More
Gender:
All
Ages:
Between 0 months and 27 months
Trial Updated:
11/16/2023
Locations: UCSF Benioff Children's Hospital - Oakland, Oakland, California
Conditions: Hearing Loss, Speech and Language Development Delay Due to Hearing Loss
Register for Updates
7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels
NCT05480761
Recruiting
This is a Phase 4, U.S. only, multi-center study using a 7-day therapeutic response dose (TRD) of commercial Sucraid® to assess the response of treatment in 1100 symptomatic pediatric (6 months to 17 years old) subjects with low, moderate, and normal sucrase activity determined by a disaccharidase assay via EGD within 1 year of the Screening Visit. This study will also explore the relationship between known genetic CSID mutations and sucrase activities via (EGD) disaccharidase assay (low, modera... Read More
Gender:
All
Ages:
Between 6 months and 17 years
Trial Updated:
11/14/2023
Locations: UCSF Benioff Children's Hospital Oakland, Oakland, California
Conditions: Congenital Sucrase-Isomaltase Deficiency, CSID, Sucrase Isomaltase Deficiency
Register for Updates
Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study
NCT05568472
Recruiting
This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can... Read More
Gender:
Female
Ages:
18 years and above
Trial Updated:
11/09/2023
Locations: Bay Area Tumor Institute, Oakland, California +2 locations
Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma
Register for Updates
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT04095364
Recruiting
This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by... Read More
Gender:
Female
Ages:
18 years and above
Trial Updated:
11/07/2023
Locations: Kaiser Permanente Oakland-Broadway, Oakland, California +1 locations
Conditions: Primary Peritoneal Low Grade Serous Adenocarcinoma, Stage II Ovarian Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Low Grade Fallopian Tube Serous Adenocarcinoma, Stage II Fallopian Tube Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8, Stage III Fallopian Tube Cancer AJCC v8, Stage III Primary Peritoneal Cancer AJCC v8, Stage IV Fallopian Tube Cancer AJCC v8, Stage IV Primary Peritoneal Cancer AJCC v8, Ovarian Low Grade Serous Adenocarcinoma
Register for Updates
Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children
NCT06038617
Recruiting
This is a prospective, randomized, open-label clinical trial to evaluate the safety of COVID-19 vaccination and other routine childhood vaccines given simultaneously at Visit 1, as compared to sequential vaccination of COVID-19 vaccine and other vaccines at separate visits (Visits 1 and 2).
Gender:
All
Ages:
Between 6 months and 4 years
Trial Updated:
10/31/2023
Locations: Kaiser Permanente Northern California, Oakland, California
Conditions: Fever After Vaccination, Fever, Seizures Fever
Register for Updates
Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening
NCT04798664
Recruiting
To compare the effectiveness of four interventions to promote sustained, biochemically confirmed smoking abstinence for 6 months among underserved smokers referred for lung cancer screening at four large U.S. health systems.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/30/2023
Locations: Kaiser Permanente Southern California, Oakland, California
Conditions: Smoking Cessation
Register for Updates
Pain and Quality of Life After Retromuscular Ventral Hernia Repair (RECOVER)
NCT04487522
Recruiting
The study aims to explore the difference in outcomes relating to pain and quality of life after open, laparoscopic, and robotic-assisted retromuscular ventral hernia repair.
Gender:
All
Ages:
Between 18 years and 89 years
Trial Updated:
09/26/2023
Locations: Kaiser Foundation Research Institute, Oakland/Richmond, Oakland, California
Conditions: Ventral Hernia
Register for Updates
Myotonic Dystrophy Family Registry
NCT02398786
Recruiting
The Myotonic Dystrophy Family Registry (MDFR) is an online, patient-entered database that collects information on myotonic dystrophy (DM) to aid researchers in developing new, effective treatments and help identify participants for research studies and clinical trials.
Gender:
All
Ages:
All
Trial Updated:
09/21/2023
Locations: Myotonic Dystrophy Foundation, Oakland, California
Conditions: Myotonic Dystrophy, Congenital Myotonic Dystrophy, Myotonic Dystrophy 1, Myotonic Dystrophy 2, Dystrophia Myotonica, Dystrophia Myotonica 1, Dystrophia Myotonica 2, Myotonia Dystrophica, Myotonic Dystrophy, Congenital, Myotonic Myopathy, Proximal, PROMM (Proximal Myotonic Myopathy), Proximal Myotonic Myopathy, Steinert Disease, Steinert Myotonic Dystrophy, Steinert's Disease, Myotonia Atrophica
Register for Updates
A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)
NCT05494593
Recruiting
The main aim of this study is to evaluate the ability of a prophylactic immune tolerizing regimen (ITR) to prevent or reduce the development of high titer anti-idursulfase antibodies in treatment-naïve participants with Hunter syndrome. In this open label, single arm study, all participants will receive ELAPRASE treatment and a prophylactic ITR. Participants will be treated with ELAPRASE for up to 104 weeks. The prophylactic ITR will start 1 day prior to the start of ELAPRASE. The prophylactic... Read More
Gender:
Male
Ages:
6 years and below
Trial Updated:
09/21/2023
Locations: Children's Hospital and Research Center at Oakland, Oakland, California
Conditions: Mucopolysaccharidosis (MPS), Hunter Syndrome
Register for Updates
A Study of AAV9 Gene Therapy in Participants With Canavan Disease
NCT04998396
Recruiting
The main objective of this trial is to evaluate the safety, tolerability, and pharmacodynamic activity of BBP-812, an investigational AAV9-based gene therapy, in pediatric participants with Canavan disease.
Gender:
All
Ages:
30 months and below
Trial Updated:
09/20/2023
Locations: UCSF Benioff Children's Hospital Oakland, Oakland, California
Conditions: Canavan Disease
Register for Updates
ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPD
NCT03911505
Recruiting
This is a Phase 3, open-label, multicenter study to evaluate the safety, PK, efficacy, PD, and immunogenicity of Cipaglucosidase Alfa/Miglustat treatment in enzyme replacement therapy (ERT)-experienced and ERT-naïve pediatric subjects with Pompe disease, aged 0 to < 18 years
Gender:
All
Ages:
Between 0 years and 17 years
Trial Updated:
09/14/2023
Locations: UCSF Benioff Children's Hospital, Oakland, California
Conditions: Pompe Disease (Late-onset)
Register for Updates
Multi-Center Adolescent Clavicle Fracture Trial: Operative vs. Non-Operative Treatment
NCT04250415
Recruiting
Investigators from eight tertiary care, level 1 pediatric trauma centers have developed a protocol for the establishment of a formal, prospective multi-center adolescent clavicle registry, with designs for standardized radiographic assessment and the prospective collection of validated outcome measures and complications data, for all patients, ages 10-18, treated for clavicle shaft fractures, operatively and non-operatively. Eventually, the investigators would like to do comparative analysis for... Read More
Gender:
All
Ages:
Between 10 years and 18 years
Trial Updated:
09/14/2023
Locations: University of California San Francisco Benioff Children's Hospital Oakland, Oakland, California
Conditions: Clavicle Fracture
Register for Updates